Peter Rutherford is Global Head of World Wide Medical at Vantive.

He qualified in Medicine at the University of Newcastle upon Tyne in 1986 and commenced a career in academic nephrology, being awarded a PhD in 1994. He trained in Nephrology and Internal Medicine in the UK and as a Medical Research Council Travelling Fellow at Yale University School of Medicine, USA.

From 1996 to 2007 he was Senior Lecturer in Nephrology, Consultant Physician at the University of Wales College of Medicine and became the NHS Trust/Health Board Medical Director. He is a Fellow and Visiting Professor at Wrexham Glyndwr University.

In 2007 he moved to industry and joined Baxter Healthcare as Medical Director for Europe, Middle East and Africa. From 2015/2017 Peter was Head of Integrated Market Access for Europe and Emerging Markets at IQVIA. He became Global Medical Lead for Rare Renal Disease at Vifor Pharma in 2017 working on late development and early commercialisation of novel therapies.

In February 2021 rejoined Baxter and since the separation of Vantive is responsible for all medical aspects of new product development, sustaining products, global patient safety, physician engagement and evidence generation.